Sfoglia per ???browse.type.metadata.typeResearch??? AREA06 - SCIENZE MEDICHE
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases
2013 Voso, Maria Teresa; Fabiani, Emiliano; Fianchi, Luana; Falconi, Giulia; Criscuolo, Marianna; Santangelo, Rosaria; Chiusolo, Patrizia; Betti, Silvia; D'Alo', Francesco; Hohaus, Stefan; De Stefano, Valerio; Leone, Giuseppe
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
2012 Rossi, D; Rasi, S; Fabbri, G; Spina, V; Fangazio, M; Forconi, F; Marasca, R; Laurenti, Luca; Bruscaggin, A; Cerri, M; Monti, S; Cresta, S; Famà, R; De Paoli, L; Bulian, P; Gattei, V; Guarini, A; Deaglio, S; Capello, D; Rabadan, R; Pasqualucci, L; Dalla Favera, R; Foà, R; Gaidano, G.
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group
2016 Bresolin, S.; De Filippi, P.; Vendemini, F.; D'Alia, M.; Zecca, M.; Meyer, L. H.; Danesino, C.; Locatelli, Franco; Masetti, R.; Basso, G.; te Kronnie, G.
Mutations of the BIK gene in human peripheral B-cell lymphomas
2003 Arena, Vincenzo; Martini, Maurizio; Luongo, Myriam; Capelli, Arnaldo; Larocca, Luigi Maria
MUTYH c.933+3A > C, associated with a severely impaired gene expression, is the first Italian founder mutation in MUTYH-Associated Polyposis
2013 Pin, E; Pastrello, C; Tricarico, R; Papi, L; Quaia, M; Fornasarig, M; Carnevali, I; Oliani, C; Fornasin, A; Agostini, M; Maestro, R; Barana, D; Aretz, S; Genuardi, Maurizio; Viel, A.
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events
2013 Aretz, S; Tricarico, R; Papi, L; Spier, I; Pin, E; Horpaopan, S; Lucci Cordisco, Emanuela; Pedroni, M; Stienen, D; Gentile, A; Panza, A; Piepoli, A; De Leon, Mp; Friedl, W; Viel, A; Genuardi, Maurizio
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.
2013 Genuardi, Maurizio; Aretz, S; Tricarico, R; Papi, L; Spier, L; Pin, E; Horpaopan, S; Lucci Cordisco, L; Pedroni, M; Stienen, D; Gentile, A; Panza, A; Piepoli, A; De Leon, Mp; Friedl, W; Viel, A.
[Myasthenia and sleep]
1983 Mennuni, Gioacchino; Morante, Mt; Di Meo, L; Scoppetta, C; Strusi, L; Neri, Geraldina; Laudisio, Alfredo; Mazza, Salvatore; Bergonzi, P.
Myasthenia gravis
2019 Gilhus, Nils Erik; Tzartos, Socrates; Evoli Stampanoni-B, Amelia; Palace, Jacqueline; Burns, Ted M; Verschuuren, Jan J G M
Myasthenia gravis and associated autoimmune diseases
1994 Palmisani, Mt; Evoli, Amelia; Batocchi, Anna Paola; Bartoccioni, Emanuela; Tonali, Pietro Attilio
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor
2023 Papi, Claudia; Granata, Giuseppe; Galluzzo, M.; Iorio, Raffaele
Myasthenia gravis associated with thymoma: clinical characteristics and long-term outcome
1994 Palmisani, Mt; Evoli, Amelia; Batocchi, Anna Paola; Provenzano, Carlo; Tonali, Pietro Attilio
Myasthenia gravis during interferon alfa therapy
1995 Batocchi, Anna Paola; Evoli, Amelia; Servidei, Serenella; Palmisani, Mt; Apollo, F; Tonali, Pietro Attilio
Myasthenia gravis with antibodies to MuSK: an update
2018 Evoli Stampanoni-B, Amelia; Alboini, Paolo Emilio; Damato, Valentina; Iorio, Raffaele; Provenzano, Carlo; Bartoccioni, Emanuela; Marino, Mariapaola
Myasthenia gravis with antibodies to MuSK: another step towards solving mistery?
2011 Evoli Stampanoni-B, Amelia; Lindstrom, John
Myasthenia gravis: New developments in research and treatment
2017 Evoli Stampanoni-B, Amelia
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Iorio, Raffaele
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
2015 Mongiardi, Mp; Savino, M; Bartoli, L; Beji, S; Nanni, Simona; Scagnoli, F; Falchetti, Ml; Favia, A; Farsetti, A; Levi, A; Nasi, S; Illi, B.
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
2017 Brandetti, E.; Veneziani, I.; Melaiu, O.; Pezzolo, A.; Castellano, A.; Boldrini, R.; Ferretti, E.; Fruci, D.; Moretta, L.; Pistoia, V.; Locatelli, Franco; Cifaldi, L.
Mycobacterium tuberculosis virulence: insights and impact on vaccine development
2015 Delogu, Giovanni; Provvedi, R; Sali, Michela; Manganelli, R.
Data di pubblicazione | Titolo | Autore(i) | File |
---|---|---|---|
1-gen-2013 | Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases | Voso, Maria Teresa; Fabiani, Emiliano; Fianchi, Luana; Falconi, Giulia; Criscuolo, Marianna; Santangelo, Rosaria; Chiusolo, Patrizia; Betti, Silvia; D'Alo', Francesco; Hohaus, Stefan; De Stefano, Valerio; Leone, Giuseppe | |
1-gen-2012 | Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia | Rossi, D; Rasi, S; Fabbri, G; Spina, V; Fangazio, M; Forconi, F; Marasca, R; Laurenti, Luca; Bruscaggin, A; Cerri, M; Monti, S; Cresta, S; Famà, R; De Paoli, L; Bulian, P; Gattei, V; Guarini, A; Deaglio, S; Capello, D; Rabadan, R; Pasqualucci, L; Dalla Favera, R; Foà, R; Gaidano, G. | |
1-gen-2016 | Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group | Bresolin, S.; De Filippi, P.; Vendemini, F.; D'Alia, M.; Zecca, M.; Meyer, L. H.; Danesino, C.; Locatelli, Franco; Masetti, R.; Basso, G.; te Kronnie, G. | |
1-gen-2003 | Mutations of the BIK gene in human peripheral B-cell lymphomas | Arena, Vincenzo; Martini, Maurizio; Luongo, Myriam; Capelli, Arnaldo; Larocca, Luigi Maria | |
1-gen-2013 | MUTYH c.933+3A > C, associated with a severely impaired gene expression, is the first Italian founder mutation in MUTYH-Associated Polyposis | Pin, E; Pastrello, C; Tricarico, R; Papi, L; Quaia, M; Fornasarig, M; Carnevali, I; Oliani, C; Fornasin, A; Agostini, M; Maestro, R; Barana, D; Aretz, S; Genuardi, Maurizio; Viel, A. | |
1-gen-2013 | MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events | Aretz, S; Tricarico, R; Papi, L; Spier, I; Pin, E; Horpaopan, S; Lucci Cordisco, Emanuela; Pedroni, M; Stienen, D; Gentile, A; Panza, A; Piepoli, A; De Leon, Mp; Friedl, W; Viel, A; Genuardi, Maurizio | |
1-gen-2013 | MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events. | Genuardi, Maurizio; Aretz, S; Tricarico, R; Papi, L; Spier, L; Pin, E; Horpaopan, S; Lucci Cordisco, L; Pedroni, M; Stienen, D; Gentile, A; Panza, A; Piepoli, A; De Leon, Mp; Friedl, W; Viel, A. | |
1-gen-1983 | [Myasthenia and sleep] | Mennuni, Gioacchino; Morante, Mt; Di Meo, L; Scoppetta, C; Strusi, L; Neri, Geraldina; Laudisio, Alfredo; Mazza, Salvatore; Bergonzi, P. | |
1-gen-2019 | Myasthenia gravis | Gilhus, Nils Erik; Tzartos, Socrates; Evoli Stampanoni-B, Amelia; Palace, Jacqueline; Burns, Ted M; Verschuuren, Jan J G M | |
1-gen-1994 | Myasthenia gravis and associated autoimmune diseases | Palmisani, Mt; Evoli, Amelia; Batocchi, Anna Paola; Bartoccioni, Emanuela; Tonali, Pietro Attilio | |
1-gen-2023 | Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor | Papi, Claudia; Granata, Giuseppe; Galluzzo, M.; Iorio, Raffaele | |
1-gen-1994 | Myasthenia gravis associated with thymoma: clinical characteristics and long-term outcome | Palmisani, Mt; Evoli, Amelia; Batocchi, Anna Paola; Provenzano, Carlo; Tonali, Pietro Attilio | |
1-gen-1995 | Myasthenia gravis during interferon alfa therapy | Batocchi, Anna Paola; Evoli, Amelia; Servidei, Serenella; Palmisani, Mt; Apollo, F; Tonali, Pietro Attilio | |
1-gen-2018 | Myasthenia gravis with antibodies to MuSK: an update | Evoli Stampanoni-B, Amelia; Alboini, Paolo Emilio; Damato, Valentina; Iorio, Raffaele; Provenzano, Carlo; Bartoccioni, Emanuela; Marino, Mariapaola | |
1-gen-2011 | Myasthenia gravis with antibodies to MuSK: another step towards solving mistery? | Evoli Stampanoni-B, Amelia; Lindstrom, John | |
1-gen-2017 | Myasthenia gravis: New developments in research and treatment | Evoli Stampanoni-B, Amelia | |
1-gen-2024 | Myasthenia gravis: the changing treatment landscape in the era of molecular therapies | Iorio, Raffaele | |
1-gen-2015 | Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells | Mongiardi, Mp; Savino, M; Bartoli, L; Beji, S; Nanni, Simona; Scagnoli, F; Falchetti, Ml; Favia, A; Farsetti, A; Levi, A; Nasi, S; Illi, B. | |
1-gen-2017 | MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma | Brandetti, E.; Veneziani, I.; Melaiu, O.; Pezzolo, A.; Castellano, A.; Boldrini, R.; Ferretti, E.; Fruci, D.; Moretta, L.; Pistoia, V.; Locatelli, Franco; Cifaldi, L. | |
1-gen-2015 | Mycobacterium tuberculosis virulence: insights and impact on vaccine development | Delogu, Giovanni; Provvedi, R; Sali, Michela; Manganelli, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile